Global Sanger Sequencing Service Market Growth (Status and Outlook) 2025-2031

The global Sanger Sequencing Service market size is predicted to grow from US$ 209 million in 2025 to US$ 207 million in 2031; it is expected to grow at a CAGR of -0.2% from 2025 to 2031.

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.

LPI (LP Information)' newest research report, the “Sanger Sequencing Service Industry Forecast” looks at past sales and reviews total world Sanger Sequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Sanger Sequencing Service sales for 2025 through 2031. With Sanger Sequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sanger Sequencing Service industry.

This Insight Report provides a comprehensive analysis of the global Sanger Sequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sanger Sequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sanger Sequencing Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sanger Sequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sanger Sequencing Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Sanger Sequencing Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
PCR Products
Plasmid DNA
Bacterial Artificial Chromosomes (BAC)
Others

Segmentation by Application:
Research Institutions
Biotech Companies
Universities and Colleges
Hospitals and Clinics
Pharmaceutical Companies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver.